Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Asset Utilization Ratio: 2021-2023

Historic Asset Utilization Ratio for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to 0.11.

  • ADC Therapeutics' Asset Utilization Ratio fell 59.27% to 0.11 in Q3 2023 from the same period last year, while for Sep 2023 it was 0.11, marking a year-over-year decrease of 59.27%. This contributed to the annual value of 0.00 for FY2022, which is N/A change from last year.
  • ADC Therapeutics' Asset Utilization Ratio amounted to 0.11 in Q3 2023, which was down 53.88% from 0.24 recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Asset Utilization Ratio peaked at 112.26 during Q1 2021, and registered a low of 0.02 during Q3 2021.
  • Over the past 3 years, ADC Therapeutics' median Asset Utilization Ratio value was 0.24 (recorded in 2023), while the average stood at 15.44.
  • Over the last 5 years, ADC Therapeutics' Asset Utilization Ratio had its largest YoY gain of 1,149.37% in 2022, and its largest YoY loss of 99.81% in 2022.
  • Quarterly analysis of 3 years shows ADC Therapeutics' Asset Utilization Ratio stood at 0.04 in 2021, then skyrocketed by 645.96% to 0.27 in 2022, then plummeted by 59.27% to 0.11 in 2023.
  • Its Asset Utilization Ratio stands at 0.11 for Q3 2023, versus 0.24 for Q2 2023 and 0.24 for Q1 2023.